Results 71 to 80 of about 9,286 (149)

Multi-Criteria Decision Analysis using Physician Preferences from a Global Discrete Choice Experiment to Investigate the Selection of Preemptive Antiviral Treatments for Post-Hematopoietic Cell Transplant Cytomegalovirus Infection. [PDF]

Open Forum Infect Dis
Perales MA, Young JH, Tervonen T, Deparis S, Norton JD, Gugiu C, Bo T, Davis K, Quan S, Prince VL, Abou Ali A, Auciello J.   +11 more
europepmc   +1 more source

Maribavir for the Management of a Complex Cytomegalovirus (CMV) Infection After Liver Transplantation: Refractoriness and Intolerance to Standard Therapies in the Intensive Care Unit. [PDF]

Cureus
Santos L, Inácio H, Cochicho Ramalho A, Rodeia SC, Germano N.   +4 more
europepmc   +1 more source

Disseminated Ganciclovir-Resistant Cytomegalovirus in a Nontransplant Pediatric ALL Patient: A Case Report. [PDF]

J Pediatr Hematol Oncol
Collazo-Roman M, O'Connor J, Wilson WS, Smitherman A, Belhorn T, Willis Z.   +5 more
europepmc   +1 more source

Management of cytomegalovirus reactivation and immunosuppression following uterus transplantation. [PDF]

Clinics (Sao Paulo)
Song ATW, Ejzenberg D, Silva MS, Santos VR, Pinheiro RSN, Waisberg DR, Haddad LBP, Abdala E, Carvalho MHB, Soares Junior JM, Baracat EC, Andraus W.   +11 more
europepmc   +1 more source

Short and Long-Term Outcomes in Kidney Transplant Recipients with Neutropenia or Leukopenia Following CMV Prophylaxis. [PDF]

J Health Econ Outcomes Res
Turzhitsky V, Li Q, Ai L, Jootun M, Wang W, Beyer A, Moise P, Kolobova I.   +7 more
europepmc   +1 more source

A comparative in silico and in vitro analysis of antiviral agents targeting estrogen and progesterone receptors in breast cancer. [PDF]

Sci Rep
Mugundan UM, Saravanan V, Ganesan RM.
europepmc   +1 more source

Maribavir for Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients: A Case Series. [PDF]

IJU Case Rep
Takamoto D, Shimada Y, Hasegawa Y, Noguchi T, Kawahara T, Teranishi J, Makiyama K.   +6 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial. [PDF]

EClinicalMedicine
Jacobs TG, Mumbiro V, Tembo J, Egbe FN, Moraleda C, Beca LSDAB, Passanduca A, Kakooza L, Chitsamatanga M, Nduna B, Bramugy J, Tagarro A, Chhaganlal KD, Mutesi S, Mark NL, Bwakura-Dangarembizi M, Namuzizya N, Ballesteros A, Dominguez-Rodríguez S, Colbers A, Sacarlal J, Nalwanga D, Mujuru HA, Chabala C, Madrid L, Buck WC, Musiime V, Bates M, Rojo P, Burger DM, EMPIRICAL Clinical Trial Group.   +30 more
europepmc   +1 more source

Optimization of Valganciclovir for Treatment of Cytomegalovirus Infection in Pediatric Liver Transplant Recipients: A Prospective Pharmacokinetic Study. [PDF]

Transplant Direct
Shoji K, Saito J, Futatsugi R, Ikuse T, Kasai T, Matsui T, Yamada M, Ogimi C, Uchida H, Fukuda A, Sakamoto S, Kasahara M.   +11 more
europepmc   +1 more source

Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis. [PDF]

Infect Control Hosp Epidemiol
Enriquez KT, Dulanto Chiang A, Smiley C, Staub M.   +3 more
europepmc   +1 more source